Financhill
Back

CytomX Therapeutics Stock Predictions

CytomX Therapeutics Stock Forecast

  • Is CytomX Therapeutics Stock Undervalued?
    The current CytomX Therapeutics [CTMX] share price is $1.07. The Score for CTMX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • CTMX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will CytomX Therapeutics Stock Go Up Next Year?

Data Unavailable

CytomX Therapeutics Stock Rating

Data Unavailable

CytomX Therapeutics Stock Price History

Is CTMX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTMX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytomx.com

52-Week Data

52-Week High:
5.85
52-Week Low:
0.83

Prediction Charts

Market Cap:
83.7M
Price in USD:
1.07
Volume:
1.5M
Beta:
0.94

Technical Analysis

SMA50:
1.06
SMA100:
1.13
SMA200:
1.50
52-Wk Change:
-25.69%

Stock Predictions

  • Is CytomX Therapeutics stock public?
    Yes, CytomX Therapeutics is a publicly traded company.
  • What is the CytomX Therapeutics stock quote today?
    The CytomX Therapeutics stock price is 1.07 USD today.
  • How to buy CytomX Therapeutics stock online?
    You can buy CytomX Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 1.27 1.16 1.28 1.13
Dec-6 1.19 1.18 1.25 1.17
Dec-9 1.23 1.26 1.28 1.19
Dec-10 1.24 1.21 1.25 1.17
Dec-11 1.24 1.18 1.25 1.15
Dec-12 1.17 1.12 1.17 1.08
Dec-13 1.13 1.11 1.13 1.05
Dec-16 1.12 1.15 1.16 1.09
Dec-17 1.14 1.13 1.15 1.06
Dec-18 1.12 1.06 1.12 1.00
Dec-19 1.07 1.10 1.13 1.03
Dec-20 1.06 1.09 1.10 1.03
Dec-23 1.06 1.09 1.11 1.05
Dec-24 1.06 1.07 1.10 1.06

CytomX Therapeutics Earnings

Data Unavailable

CytomX Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.44 per share.

* CytomX Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.